Patent ID: 11951212
Assignee: VERTEX PHARMACEUTICALS INCORPORATED
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 34:
35. A method of treating cystic fibrosis in a patient comprising orally administering to the patient a tablet comprising:
a first solid dispersion which comprises 80 wt % of amorphous Compound 1 relative to the total weight of the first solid dispersion and 20 wt % of polymer relative to the total weight of the first solid dispersion,
a second solid dispersion which comprises 80 wt % of amorphous Compound 2 relative to the total weight of the second solid dispersion, 19.5 wt % of polymer relative to the total weight of the second solid dispersion, and 0.5 wt % of sodium lauryl sulfate relative to the total weight of the second solid dispersion, and
wherein the tablet comprises 100 mg of Compound 1 and 150 mg of Compound 2.